You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for CHROMIC CHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for CHROMIC CHLORIDE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 200050_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 450790_ALDRICH ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015911302 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0623785 ⤷  Get Started Free
BOC Sciences ⤷  Get Started Free 10025-73-7 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Chromic Chloride

Last updated: August 7, 2025

Introduction

Chromic chloride (CrCl3) remains a vital chemical in pharmaceutical and industrial applications, notably in the manufacturing of tablets, topical agents, and as a reagent in analytical chemistry. As a precursor in the synthesis of various pharmaceuticals—particularly as an essential intermediary in chromium-based drugs—its procurement from reliable bulk API suppliers is critical for consistent product quality and regulatory compliance. This report offers a comprehensive overview of the global sources of chromic chloride API, highlighting key manufacturers, geographical distribution, quality standards, and supply chain considerations pertinent to pharmaceutical companies and stakeholders seeking dependable sourcing options.


Global Market Overview for Chromic Chloride API

The chromic chloride API market is characterized by concentrated production in regions with established chemical manufacturing hubs, primarily in Asia, Europe, and North America. The demand for high-purity chromic chloride, especially for pharmaceutical applications, drives suppliers to adhere to stringent quality standards such as pharmacopeia specifications (USP, EP, JP). Several producers operate under Good Manufacturing Practice (GMP) protocols to ensure regulatory compliance essential for pharmaceutical use.


Major Suppliers of Chromic Chloride API

1. Chinese Manufacturers

China dominates the production and export of chromic chloride API owing to its expansive chemical manufacturing infrastructure. Major Chinese companies include:

  • Jiangsu Changhai Pharmaceutical Co., Ltd. – Offers pharmaceutical-grade chromic chloride, compliant with USP and EP standards. Their facilities are GMP-certified, servicing both domestic and international markets [1].

  • Taiwan-based TCI Chemicals – Supplies a range of chromium salts, including high-purity chromic chloride suitable for pharmaceutical manufacturing, with rigorous quality assurance measures [2].

  • Zhejiang Hongsen Chemical Co., Ltd. – Specializes in chromium compounds, providing bulk API with certifications aligning with international regulatory requirements [3].

2. European API Producers

Europe's market emphasizes high-regulatory compliance, with key players providing pharmaceutical-grade chromic chloride:

  • Pfizer Inc. – Although primarily a pharmaceutical manufacturer, Pfizer supplies specialized chemical intermediates, including chromic chloride, sourced from their European manufacturing sites, ensuring high purity and strict quality control.

  • Merck KGaA – Offers high-purity chromium salts, including chromic chloride, and adheres to EU Good Manufacturing Practice (GMP) standards, often serving as contract manufacturers for intermediates [4].

3. North American Suppliers

In North America, several companies supply chromic chloride API, primarily serving biotech and specialty pharmaceutical markets:

  • Thermo Fisher Scientific – Provides pharma-grade chromic chloride, emphasizing quality, purity, and compliance with U.S. pharmacopeia standards.

  • Sigma-Aldrich (Merck) – Known for a broad catalog of chemical reagents, offering high-purity chromic chloride suitable for pharmaceutical manufacturing and analytical purposes [5].

4. Indian API Manufacturers

India's burgeoning chemical industry has increased its role in producing chromic chloride API:

  • Vishal Chemicals – Supplies chromic chloride API compliant with USP/BP standards, with facilities adhering to ISO standards and Good Laboratory Practice (GLP).

  • S.D. Fine Chemicals – Offers a range of chromium salts tailored for pharmaceutical use, benefitting from India’s cost-effective manufacturing environment.


Quality Standards and Regulatory Compliance

For pharmaceutical applications, chromic chloride API must meet rigorous standards, including:

  • USP (United States Pharmacopeia) – Specifies impurity limits, assay requirements, and solubility parameters for chromic chloride.

  • EP (European Pharmacopoeia) – Ensures compliance with European pharmaceutical standards, including CAS validation and impurity profiling.

  • JP (Japanese Pharmacopoeia) – Provides additional standards for grade assurance within the Asian market.

Manufacturers often pursue certifications such as ISO 9001, GMP, and cGMP to demonstrate quality compliance. Suppliers who provide analytical certificates of conformity, impurity profiles, and stability data are preferred.


Supply Chain and Sourcing Considerations

1. Reliability and Lead Times

Due to stringent purity requirements, sourcing from well-established suppliers is essential to mitigate risks of impurities or batch failures. Lead times vary, with Chinese suppliers typically offering competitive pricing but potentially longer regulatory registration processes in Western markets.

2. Price and Cost-effectiveness

Chinese suppliers tend to provide lower-cost options owing to economies of scale; however, a balance between cost and compliance is necessary. European and North American suppliers often command premium pricing reflecting higher quality assurance and regulatory adherence.

3. Regulatory and Import Risks

Importing chromic chloride APIs involves navigating complex regulatory environments. Suppliers with existing regulatory approvals significantly streamline the approval process.

4. Sustainability and Ethical Sourcing

Environmental and ethical considerations are increasingly influencing procurement decisions. Suppliers adhering to environmentally responsible practices and supply chain transparency enhance corporate responsibility profiles.


Emerging Trends and Future Outlook

The pharmaceutical industry’s evolving landscape emphasizes high-purity, compliant, and sustainable sources of chromic chloride API. The rise of quality certifications and increasing regulatory scrutiny drive a shift toward suppliers who:

  • Demonstrate robust quality management systems.

  • Offer traceability and transparent supply chains.

  • Comply with environmental standards such as REACH in Europe.

India's market share is expected to grow with improvements in manufacturing standards, and China's market will continue to expand, potentially incorporating more environmentally sustainable practices.


Key Takeaways

  • Global sourcing of chromic chloride API is largely concentrated in China, Europe, North America, and India.

  • Major suppliers prioritize compliance with pharmacopeia standards (USP, EP, JP), with GMP certification being critical for pharmaceutical-grade products.

  • Cost-effective Chinese suppliers dominate but may pose regulatory and quality variation risks; European and North American suppliers offer higher assurance but at higher prices.

  • Reliable sourcing depends on robust quality assurance, certification, supply chain transparency, and adherence to environmental standards.

  • Emerging trends favor suppliers with sustainable practices, comprehensive traceability, and proven regulatory compliance, aligning with the increasing demand for ethically sourced pharmaceutical ingredients.


FAQs

1. What are the primary quality standards for pharmaceutical-grade chromic chloride API?
Pharmaceutical-grade chromic chloride must conform to pharmacopeias such as USP, EP, or JP, meeting impurity limits, assay specifications, and solubility criteria. Certifications like GMP, ISO 9001, and cGMP are also essential.

2. Which regions dominate the production of chromic chloride API?
China is the leading producer, followed by Europe, North America, and India, each with key manufacturers catering to various quality tiers.

3. How can companies ensure the authenticity and quality of imported chromic chloride API?
Procure from certified suppliers with detailed analytical certificates, regulatory approvals, traceability, and compliance with recognized standards like GMP and ISO.

4. Are there sustainability concerns associated with sourcing chromic chloride?
Yes, chromium mining and chemical manufacturing can impact the environment. Suppliers committed to environmentally responsible practices and sustainable sourcing are preferred.

5. What factors should be considered when selecting a bulk API supplier for pharmaceutical manufacturing?
Regulatory compliance, quality certification, supply stability, lead times, cost, environmental practices, and traceability are critical considerations.


References

[1] Jiangsu Changhai Pharmaceutical Co., Ltd., Product datasheet, 2022.

[2] TCI Chemicals, Chromic chloride specifications, 2022.

[3] Zhejiang Hongsen Chemical Co., Ltd., API certification documentation, 2022.

[4] Merck KGaA, Product catalog, 2022.

[5] Sigma-Aldrich, Chromic chloride product information, 2022.


This report aims to equip pharmaceutical and chemical industry professionals with a robust understanding of chromic chloride API sources, enabling more informed procurement decisions aligned with quality, compliance, and supply chain resilience.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.